Environmental oxygen affects ex vivo growth and proliferation of mesenchymal progenitors by modulating mitogen-activated protein kinase and mammalian target of rapamycin signaling

Cytotherapy. 2022 Dec;24(12):1201-1210. doi: 10.1016/j.jcyt.2022.06.005. Epub 2022 Sep 13.

Abstract

Background aims: Stem and progenitor cells of hematopoietic and mesenchymal lineages reside in the bone marrow under low oxygen (O2) saturation. O2 levels used in ex vivo expansion of multipotent mesenchymal stromal cells (MSCs) affect proliferation, metabolism and differentiation.

Methods: Using cell-based assays and transcriptome and proteome data, the authors compared MSC cultures simultaneously grown under a conventional 19.95% O2 atmosphere or at 5% O2.

Results: In 5% O2, MSCs showed better proliferation and higher self-renewal ability, most probably sustained by enhanced signaling activity of mitogen-activated protein kinase and mammalian target of rapamycin pathways. Non-oxidative glycolysis-based energy metabolism supported growth and proliferation in 5% O2 cultures, whereas MSCs grown under 19.95% O2 also utilized oxidative phosphorylation. Cytoprotection mechanisms used by cells under 5% O2 differed from 19.95% O2 suggesting differences in the triggers of cell stress between these two O2 conditions.

Conclusions: Based on the potential benefits for the growth and metabolism of MSCs, the authors propose the use of 5% O2 for MSC culture.

Keywords: cell manufacturing; mesenchymal progenitor cells; mesenchymal stromal cells; proteomics; stem cell metabolism.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell Differentiation / physiology
  • Cell Proliferation
  • Cells, Cultured
  • Mitogen-Activated Protein Kinases*
  • Oxygen* / metabolism
  • Sirolimus
  • TOR Serine-Threonine Kinases

Substances

  • Oxygen
  • Mitogen-Activated Protein Kinases
  • Sirolimus
  • TOR Serine-Threonine Kinases